APR January/February 2022 - 2

American Pharmaceutical Review
Published by
POSTMASTER: Send change of addresses to
American Pharmaceutical Review, 395 Oyster Point Blvd. #300,
South San Francisco, CA 94080.
Publication Agreement #40739004.
Return undeliverable Canadian addresses to:
CompareNetworks, Inc.
Editorial
EDITOR-IN-CHIEF | Mike Auerbach
mauerbach@comparenetworks.com
WEB CONTENT MANAGER | Douglas Franklin
dfranklin@comparenetworks.com
Sales
NATIONAL SALES MANAGER | Laura Zoibi Rice
lrice@aprpub.com
Production
ART DIRECTOR | Jennifer Campbell
jcampbell@comparenetworks.com
PRODUCTION MANAGER | Allison Chelminiak
achelminiak@comparenetworks.com
Corporate
CEO | Paul Gatti
GROUP PUBLISHER | Laura Zoibi Rice
ACCOUNT COORDINATOR | Ashley Poste
American Pharmaceutical Review (ISSN 1099-8012) is published
seven times a year (February, March, April, June, August,
October, December) by CompareNetworks, Inc.
395 Oyster Point Blvd. #300 South San Francisco, CA 94080.
Subscription Rate (7 issues) 1 year $135.00.
Periodicals postage paid at South San Francisco, CA 94080
and additional mailing offices.
395 Oyster Point Blvd. #300
South San Francisco, CA 94080
www.comparenetworks.com
E-mail: info@comparenetworks.com
Website: www.americanpharmaceuticalreview.com
Printed in the USA
IMEX, PO Box 25542, London, ON N6C 6B2, Canada,
Email: info@comparenetworks.com
Copyright rests with the publishers.
All rights reserved ©2022
CompareNetworks, Inc.
No part of this publication may be reproduced, stored in a
retrieval system or transmitted in any form or by any means
electronic, mechanical, photocopying, recording or otherwise
without the prior written permission of the copyright holder.
While the publishers believe that all information contained in
this publication was correct at the time of going to press, they
can accept no liability for any inaccuracies that may appear or
loss suffered directly or indirectly by any reader as a result of
any advertisement, editorial, photographs or other material
published in American Pharmaceutical Review.
LIVE WEBINAR
March 17th, 2022
10 a.m. PT, 1 p.m. ET
Viral Control in Pharmaceutical Processing
Biological and biotechnological products are at risk from viruses. With such products the potential for
transmission of viral diseases is a real risk. Contamination can affect raw materials, cell culture processes,
bioreactor contamination and downstream processing. It is for these reasons that organizations need
to practice viral safety and control. In addition, a science-based testing regime must be in place.
It is also important to incorporate virus clearance into the manufacturing process. This webinar
discusses the essential elements of control, testing, and remediation and it includes a spotlight on the
maim viruses of concern.
In this webinar you'll learn:
* Primary risks to biohpharmaceutical processing from viruses
* The methods that can be implemented to control and remove viruses
* The test methods and testing strategy
Who should attend:
* Biotechnologists
* Biopharmaceutical professionals
* R&D scientists
* Microbiologists
2 |
| January/February 2022
REGISTER at
https://bit.ly/3uhNPo4
SPEAKERS:
Dr. Tim Sandle
(Presenter)
Head of GxP Compliance
BPL
Mike Auerbach
(Moderator)
Editor-in-Chief,
American Pharmaceutical Review
* Contamination control experts
* Manufacturing managers
* Quality Control / Quality Assurance
* Analytical Development Scientists

http://www.comparenetworks.com http://www.americanpharmaceuticalreview.com https://www.bit.ly/3uhNPo4

APR January/February 2022

Table of Contents for the Digital Edition of APR January/February 2022